Bernd Riedl

This inventor holds 30 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Kinase Inhibitors. Top assignees: Bayer Aktiengesellschaft, Bayer Healthcare LLC, Bayer Pharmaceuticals Corporation. Active years: 1996-2016.

USPTO Granted Patents = 30 (Patent Applications = 17)

% Patents Active = 50.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 7.8

ph-index = 18

Forward Citations = 692(Granted Patents)

Company Filing History:

14 out of 12,266

Bayer Aktiengesellschaft

Bayer Pharmaceuticals Corporation

patents

4. 1 out of 53

Aicuris Gmbh + Co. Kg.

patents

5. 1 out of 721

Bayer Intellectual Property Gmbh

patents

6. 1 out of 386

Bayer Pharma Aktiengesellschaft

patents

Years Active: 1996-2016

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Antiviral Agents

Oxazolidinones

Benzoxazoles

Aryl Ureas

Pyridine Compounds

Pulmonary Hypertension

CNS Diseases

Matrix Metalloprotease

Heteroaryl Compounds

Diphenyl Ureas

Substituted Compounds

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9493472 - Substituted benzoxazoles (2016-11-15),

2. 9181188 - Aryl ureas as kinase inhibitors (2015-11-10),

3. 8841330 - Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors (2014-09-23),

4. 8637553 - Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions (2014-01-28),

5. 8318761 - Substituted arylsulfonamides as antiviral agents (2012-11-27),

6. 8304406 - Compounds for treating pulmonary hypertension (2012-11-06),

7. 8124630 - ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors (2012-02-28),

8. 8110587 - Aryl ureas as kinase inhibitors (2012-02-07),

9. 8071616 - Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors (2011-12-06),

10. 7928239 - Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas (2011-04-19),

11. 7897623 - ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors (2011-03-01),

12. 7678811 - Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors (2010-03-16),

13. 7528255 - Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors (2009-05-05),

14. 7371763 - Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas (2008-05-13),

15. 7351834 - ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors (2008-04-01),

Title: Bernd Riedl - Innovative Inventor from Wuppertal

Introduction: Bernd Riedl is a renowned inventor hailing from Wuppertal, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Bernd Riedl holds several patents in various technological domains, including advancements in renewable energy, smart devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Bernd Riedl has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Bernd Riedl has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life. His collaborative spirit has led to the creation of impactful inventions.

Conclusion: Bernd Riedl's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazing inventor in Wuppertal and beyond. His work continues to inspire the next generation of inventors and shape the future of technology.